SCWO vs. AMLX
SCWO (374Water Inc. Common Stock) and AMLX (Amylyx Pharmaceuticals, Inc.) are both stocks. SCWO operates in Pollution & Treatment Controls (Industrials), while AMLX operates in Biotechnology (Healthcare). Over the past 3 years, SCWO returned -53.44%/yr vs -4.58%/yr for AMLX. Their 0.10 correlation means their historical movements had little consistent relationship.
Performance
SCWO vs. AMLX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SCWO achieves a 6.86% return, which is significantly lower than AMLX's 68.13% return.
SCWO
- 1D
- -2.68%
- 1M
- 9.55%
- 6M
- -29.90%
- YTD
- 6.86%
- 1Y
- 15.96%
- 3Y*
- -53.44%
- 5Y*
- -37.47%
- 10Y*
- 0.37%
- ALL TIME*
- -9.57%
AMLX
- 1D
- -2.12%
- 1M
- 11.17%
- 6M
- 42.13%
- YTD
- 68.13%
- 1Y
- 163.25%
- 3Y*
- -4.58%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -0.73%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $41.59M | $31.68M | $25.94M | |
| $106.33K | $109.95K | $142.12K |
SCWO vs. AMLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
SCWO 374Water Inc. Common Stock | 6.86% | -70.11% | -51.93% | -50.35% | -17.10% |
AMLX Amylyx Pharmaceuticals, Inc. | 68.13% | 219.58% | -74.32% | -60.16% | 75.95% |
Correlation
The correlation between SCWO and AMLX is 0.06, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.06 |
Correlation (3Y) Balances recent behavior with more history. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jan 7, 2022 | 0.10 |
Fundamentals
SCWO:
$38.14M
AMLX:
$2.26B
SCWO:
$0.26
AMLX:
-$1.51
SCWO:
$215.04B
AMLX:
$0.00
SCWO:
-$2.35T
AMLX:
-$20.10M
SCWO:
-$20.98T
AMLX:
-$150.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SCWO vs. AMLX — Risk / Return Rank
SCWO
AMLX
SCWO vs. AMLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for 374Water Inc. Common Stock (SCWO) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SCWO | AMLX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.59 | ||
| Sortino ratioReturn per unit of downside risk | -2.02 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.35 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | -0.15 | 5.03 | -5.18 |
| Martin ratioReturn relative to average drawdown | -0.21 | 10.76 | -10.97 |
Loading charts...
Drawdowns
SCWO vs. AMLX - Drawdown Comparison
The maximum SCWO drawdown since its inception was -99.05%, roughly equal to the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for SCWO and AMLX.
Loading charts...
Drawdown Indicators
| SCWO | AMLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.05% | -96.04% | -3.01% |
Max Drawdown (1Y)Largest decline over 1 year | -74.93% | -30.61% | -44.32% |
Max Drawdown (3Y)Largest decline over 3 years | -91.40% | -92.82% | +1.42% |
Max Drawdown (5Y)Largest decline over 5 years | -96.45% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -96.45% | — | — |
Current DrawdownCurrent decline from peak | -95.59% | -50.38% | -45.21% |
Average DrawdownAverage peak-to-trough decline | -57.08% | -59.30% | +2.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 55.25% | 14.27% | +40.98% |
Volatility
SCWO vs. AMLX - Volatility Comparison
374Water Inc. Common Stock (SCWO) has a higher volatility of 18.32% compared to Amylyx Pharmaceuticals, Inc. (AMLX) at 15.49%. This indicates that SCWO's price experiences larger fluctuations and is considered to be riskier than AMLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SCWO | AMLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.32% | 15.49% | +2.83% |
Volatility (6M)Calculated over the trailing 6-month period | 58.97% | 39.64% | +19.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 151.13% | 61.22% | +89.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 107.62% | 90.71% | +16.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 188.72% | 90.71% | +98.01% |
Dividends
SCWO vs. AMLX - Dividend Comparison
Neither SCWO nor AMLX has paid dividends to shareholders.
Financials
SCWO vs. AMLX - Financials Comparison
This section allows you to compare key financial metrics between 374Water Inc. Common Stock and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SCWO and AMLX have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SCWO has higher volatility (18.32%) compared to AMLX (15.49%). In terms of maximum drawdown, SCWO dropped -99.05% vs AMLX's -96.04%.
AMLX currently has the higher Sharpe Ratio (2.51 vs -0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SCWO and AMLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer